CANDIDA HAEMULONII IN BLOOD -- A NEW CHALLENGE

Authors

  • Sourav Maiti Institute of Neurosciences, Kolkata

Abstract

Currently, a series of cases with invasive Candida haemulonii is occurring and this is an emerging yeast pathogen for which the optimal strategy of patient management has yet to be elucidated. In this study, blood culture was done from clinical sepsis cases by BACTEC method. Yeast isolates were identified by Gram staining, germ tube test and colony morphology. Antifungal susceptibility was determined by MIC value. DNA sequencing of the strains were also performed. Candida haemulonii was isolated in 8 cases from November 2014 to August 2015. All isolates showed high level resistance to Amphotericin B, variable resistance to Flucytosine and Fluconazole, susceptibility to Echinocandins and Voriconazole. Majority of the cases had central venous catheter, prolonged broad-spectrum antimicrobial use and two also had parenteral nutrition. While, 2 cases were successfully treated with Caspofungin and Voriconazole, 4 patients could not survive but showed some improvement both by clinical and sepsis marker study (CRP, procalcitonin) with initiation of antifungal treatment. DNA sequencing showed that the isolates were Candida auris. Thus, clinically the impact of this species has been attained to some extent in this study which is immensely vital considering the very high mortality rate.

Keywords:

Candida haemulonii, Yeast, MIC, Antifungal treatment

Downloads

Download data is not yet available.

References

Crouzet, J., Sotto, A., Picard, E., Lachaud, L. & Bourgeois, N. (2011). A case of Candida haemulonii osteitis: clinical features, biochemical characteristics, and antifungal resistance profile. Cliical Microbiology Infection, 17(7), pp 1068 –1070.

Kathuria, S., Singh, P. K., Sharma, C., Prakash, A., Masih, A., Kumar, A., Meis, J. F. & Chowdhary, A. (2015). Multidrug-resistant Candida auris misidentified as Candida haemulonii: characterization by matrixassisted laser desorption ionization–time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CLSI broth microdilution, and Etest method. Journal of Clin Microbiology, 53(6), pp 1823–1830.

Khan, Z. U., Al-Sweih, N. A., Ahmad, S., Al-Kazemi, N., Khan, S., Joseph, L. & Chandy, R. (2007). Outbreak of fungemia among neonates caused by Candida haemulonii resistant to amphotericin B, itraconazole, and fluconazole. Journal of Clin Microbiology, 45(6), pp 2025-2027.

Kim, M. N., Shin, J. H., Sung, H., Lee, K., Kim, E. C., Ryoo, N., Lee, J. S., Jung, S. I., Park, K.H., Kee, S. J., Kim, S. H., Shin, M. G., Suh, S. P. & Ryang, D. W. (2009). Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features. Clinical Infectious Diseases, 48(6), pp e57– 61.

Kim, S., Ko, K. S., Moon, S. Y., Lee, M. S., Lee, M. Y. & Son, J. S. (2011). Catheter-related candidemia caused by Candida haemulonii in a patient in long-term hospital care. Journal of Korean Medecal Science, 26(2), pp 297–300.

Kurtzman, C. P., Fell, J. W. & Boekhout, T. (2011). The yeasts: a taxonomic study, 5th edition, Elsevier, Amsterdam, the Netherlands.

Lavarde, V., Daniel, F., Saez, H., Arnold, M. & Faguer, B. (1984). Peritonite mycosique a Torulopsis haemulonii. Bull. Soc. Fr. Mycol. Med, 13, pp 173–176.

Lehmann, P. F., Wu, L. C., Pruitt, W. R., Meyer, S. A. & Ahearn, D. G. (1993). Unrelatedness of groups of yeasts

within the Candida haemulonii complex. Journal of Clinical Microbiology, 31(7), pp 1683–1687.

Oh, B. J, Shin, J. H., Kim, M. N., Sung, H., Lee, K., Joo, M. Y., Shin, M. G., Suh, S. P. & Ryang, D. W. (2011). Biofilm formation and genotyping of Candida haemulonii, Candida pseudohaemulonii, and a proposed new species (Candida auris) isolates from Korea. Medical Mycology, 49(1), pp 98 –102.

Rodero, L., Cuenca-Estrella, M., Córdoba, S., Cahn, P., Davel, G., Kaufman, S., Guelfand, L. & Rodríguez-Tudela, J. L. (2002). Transient fungemia caused by an amphotericin B-resistant isolate of Candida haemulonii. Journal of Clinical Microbiolog, 40(6), pp 2266-2269.

Ruan, S. Y., Kuo, Y. W., Huang, C. T., Hsiue, H. C., Hsueh, P.R. (2010). Infections due to Candida haemulonii: species identification, antifungal susceptibility and outcomes. International Journal of Antimicrobial Agents, 35(1), pp 85– 88.

Sugita, T., Takashima, M., Poonwan, N. & Mekha, N. (2006). Candida pseudohaemulonii sp. nov., an amphotericin B- and azole-resistant yeast species, isolated from the blood of a patient from Thailand. Microbiology and Immunology, 50(6), pp 469–473.

Uden, V. & Kolipinsky, M. C. (1962). Torulopsis haemulonii nov. spec., a yeast from the Atlantic Ocean. Antonie Van Leeuwenhoek, 28, pp 78–80.

Downloads

Published

03-07-2017

How to Cite

Sourav Maiti. (2017). CANDIDA HAEMULONII IN BLOOD -- A NEW CHALLENGE . Malaysian Journal of Medical Research (MJMR), 1(3), 7-12. Retrieved from https://ejournal.lucp.net/index.php/mjmr/article/view/256

Metrics